Triphase Accelerator Corporation
Industry
- Biotechnology
- Pharmaceuticals
Other Names/Subsidiaries
- Nereus Pharmaceuticals Inc.
- Triphase Research & Development Corp.
Latest on Triphase Accelerator Corporation
Now that Bristol-Myers Squibb Co. has closed its purchase of Celgene Corp. for nearly $76bn in cash and stock, the big pharma will have to keep up the momentum within its newly acquired pipeline t
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Celgene Hopes Exscientia’s P
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Xencor Gets $120m Up Front F
There were no major surprises in Celgene Corp. 's second quarter earnings, but the financial report did ease anxiety about Otezla (apremilast) – the first major product to help the company divers